Biosante Pharmaceuticals Inc (NASDAQ:BPAX)

CAPS Rating: 2 out of 5

A biopharmaceutical company that licenses and develops hormone therapy products to treat men and women.

Recs

0
Player Avatar headyinvestor (61.01) Submitted: 1/10/2012 12:12:35 PM : Outperform Start Price: $0.57 BPAX Score: +67.97

bio-t gel approval

Report this Post Reply

Featured Broker Partners


Advertisement